Sukhmani K. Padda

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

Aadel A. Chaudhuri, Jacob J. Chabon, Alexander F. Lovejoy et al. · Cancer Discovery · 2017 · 1.1K citations · Full text

Medicine, Molecular Medicine, Oncology +17

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Branimir I. Šikić, Nehal J. Lakhani, Amita Patnaik et al. · Journal of Clinical Oncology · 2019 · 590 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer

Everett J. Moding, Yufei Liu, Barzin Y. Nabet et al. · Nature Cancer · 2020 · 370 citations · Full text

Medicine, Immunology, Oncology +17

Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition

Barzin Y. Nabet, Mohammad Shahrokh Esfahani, Everett J. Moding et al. · Cell · 2020 · 363 citations · Full text

Life Sciences, Immunology, Oncology +16

<i>KEAP1/NFE2L2</i> Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition

Michael S. Binkley, Young-Jun Jeon, Monica Nesselbush et al. · Cancer Discovery · 2020 · 173 citations · Full text

Medicine, Molecular Biology, Oncology +17